Modified apelin polypeptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9593153
APP PUB NO 20150072932A1
SERIAL NO

14391404

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to polypeptides and their uses as apelin inhibitors. More particularly, the present invention relates to a polypeptide comprising the sequence as set forth in SEQ ID NO:1 wherein at least one arginine residue at position 18, 19, 22 or 23 has been substituted or deleted.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITE PARIS-SUD XI15 RUE GEORGES CLÉMENCEAU ORSAY CEDEX 91405
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)PARIS FRA
UNIVERSITE DE BORDEAUX35 PLACE PEY BERLAND BORDEAUX 33000

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Khatib, Abdel-Majid Talence, FR 5 0
Siegfried, Geraldine Kremlin Bicetre, FR 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 14, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00